Time-to-Detection in Culture of Mycobacterium Tuberculosis

Sponsor

Centre Hospitalier Universitaire de Nice (Other)

Overall Status

Completed

CT.gov ID

NCT05568368

Collaborator

(none)

705

Enrollment

Location

Actual Duration (Months)

116.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

determination if time-to-detection in cultures of M. tuberculosis samples is more discriminating than acid-fast staining in transmission

Condition or Disease	Intervention/Treatment	Phase
Pulmonary Tuberculoses	Other: No intervention

Study Design

Study Type:

Observational

Actual Enrollment :

705 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Time-to-Detection in Culture of Mycobacterium Tuberculosis : Performance for Assessing Index Cases Infectivity

Actual Study Start Date :

Mar 15, 2022

Actual Primary Completion Date :

Sep 15, 2022

Actual Study Completion Date :

Sep 15, 2022

Arms and Interventions

Arm	Intervention/Treatment
Index cases	Other: No intervention no intervention

Arm

Intervention/Treatment

Index cases

Other: No intervention

no intervention

Outcome Measures

Primary Outcome Measures

tuberculosis transmission [2 months]
duration of Tuberculosis transmission between an infected person and a contact case
contact case tracking [2 months]
screening time for contact cases

Eligibility Criteria

Criteria

Ages Eligible for Study:

2 Years to 94 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

have at least 1 contact case explored for tuberculosis
latent tuberculosis infection

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Nice University Hospital	Nice		France	06000

Sponsors and Collaborators

Centre Hospitalier Universitaire de Nice

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Centre Hospitalier Universitaire de Nice

ClinicalTrials.gov Identifier:

NCT05568368

Other Study ID Numbers:

22Infectio01

First Posted:

Oct 5, 2022

Last Update Posted:

Oct 5, 2022

Last Verified:

Oct 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Tuberculosis

Tuberculosis, Pulmonary

Study Results

No Results Posted as of Oct 5, 2022